Literature DB >> 33415358

Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update.

Jean-François Korobelnik1,2, Anat Loewenstein3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33415358      PMCID： PMC7790333          DOI： 10.1007/s00417-020-05042-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  Addressing COVID-19 fear to improve clinic attendance for patients with wet age-related macular degeneration.

Authors:  Timothy H M Fung; Mong-Loon Kuet; Moneesh K Patel; Pankaj Puri
Journal:  Acta Ophthalmol       Date:  2020-06-18       Impact factor: 3.761

Review 2.  Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic.

Authors:  Jean-François Korobelnik; Anat Loewenstein; Bora Eldem; Antonia M Joussen; Adrian Koh; George N Lambrou; Paolo Lanzetta; Xiaoxin Li; Monica Lövestam-Adrian; Rafael Navarro; Annabelle A Okada; Ian Pearce; Francisco J Rodríguez; David T Wong; Lihteh Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-04-23       Impact factor: 3.117

Review 3.  Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure.

Authors:  Jean-François Korobelnik; Anat Loewenstein; Bora Eldem; Antonia M Joussen; Adrian Koh; George N Lambrou; Paolo Lanzetta; Xiaoxin Li; Monica Lövestam-Adrian; Rafael Navarro; Annabelle A Okada; Ian Pearce; Francisco J Rodríguez; David T Wong; Lihteh Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-02       Impact factor: 3.117

4.  Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK.

Authors:  Darren Shu Jeng Ting; Sherine Krause; Dalia G Said; Harminder S Dua
Journal:  Eye (Lond)       Date:  2020-08-10       Impact factor: 3.775

5.  Communicating with patients with nAMD and their families during the COVID-19 pandemic.

Authors:  Jean-François Korobelnik; Anat Loewenstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-04-22       Impact factor: 3.535
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.